Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Cliff Owen / AP
A bill drastically reforming federal medical malpractice law — capping damages for plaintiffs and lowering fees for attorneys — passed the House last month with no hearings in a form nearly identical to a version drafted by the Physicians Insurers Association of America, a lobbyist group for doctors and their insurers, leading the group to publicly boast about its achievement, per the Washington Post.
Bills don't often move through a whole chamber of Congress without any edits, especially on such a complicated topic. Moreover, this bill didn't have any public hearings — a practice that some on the left argue is beneficial for lobbyists and special interest groups.
Why it matters: Lobbyists — and their influence — are a fact of life in Washington, impacting nearly every piece of legislation. However, the House's move to push through a far-reaching malpractice bill without any public input is unusual. The bill has languished in the Senate thus far and if it ever got a vote, it would be unlikely to get the 60 votes needed to pass.